XML 30 R16.htm IDEA: XBRL DOCUMENT v3.26.1
Note 10 - Shareholders' Equity
 6 Months Ended
Jun. 30, 2026
Notes to Financial Statements  
Equity [Text Block]

10.

Shareholders’ Equity

 

Authorized capital stock

 

DiaMedica has authorized share capital of an unlimited number of common voting shares, and the shares do not have a stated par value. Common shareholders are entitled to receive dividends as declared by the Company, if any, and are entitled to one vote per share at the Company’s annual general meeting and any extraordinary or special general meeting.

 

Equity issued during the six months ended June 30, 2026

 

During the six months ended June 30, 2026, 181,649 common shares were issued upon the exercise of stock options for gross proceeds of $555,000 and 1,678 common shares were issued upon the vesting and settlement of restricted stock units.

 

Equity issued during the six months ended June 30, 2025

 

During the six months ended June 30, 2025, 103,875 common shares were issued upon the exercise of stock options for gross proceeds of $257,000, 142,345 shares were issued upon the settlement of deferred share units and 7,608 common shares were issued upon the vesting and settlement of restricted stock units.

 

At-the-Market Offering Program

 

We are party to a Sales Agreement under which we may, from time to time, sell voting common shares having an aggregate offering price of up to $100 million, through an “at-the-market” (ATM) offering. The sales agent receives a customary commission from the Company for any common shares sold under the ATM offering. The offer and sale of any shares sold in the ATM offering is pursuant to an effective registration statement on Form S-3 and an accompanying prospectus. As of June 3, 2026, $86.2 million remained available for issuance pursuant to the ATM offering.

 

Shares reserved

 

Common shares reserved for future issuance are as follows:

 

   

June 30, 2026

  

Issuable upon exercise of employee and non-employee stock options

     8,180,495  

Issuable upon settlement of deferred stock units

     190,785  

Issuable upon vesting and settlement of restricted stock units

     1,677  

Available for grant under the Amended and Restated 2019 Omnibus Incentive Plan

     2,989,251  

Available for grant under the 2021 Employment Inducement Incentive Plan

     528,125  

Total

     11,890,333